Sylvie Alonso

Alonso Sylvie

  • Associate Professor, Department of Microbiology and Immunology
Academic Qualifications
  • PhD, Universite Claude Bernard Lyon I, France
  • BSc, Universite Claude Bernard Lyon I, France
Research Interest(s)
  • Dengue
  • Tuberculosis
  • HFMD
  • Mouse Models
  • Therapeutics Testing
Recent Publications
  • 1. Lam JH, Chua YL, Lee PX, Martínez Gómez JM, Ooi EE, Alonso S. 2017 Dec. Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies. JCI Insight. 2(24). doi: 10.1172/jci.insight.94500.
  • 2. Park HY, Tan PS, Kavishna R, Ker A, Lu J, Chan CEZ, Hanson BJ, MacAry PA, Caminschi I, Shortman K et al. 2017 Nov. Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells. NPJ Vaccines. 2:31. doi: 10.1038/s41541-017-0033-5.
  • 3. Cho SSL, Han J, James SJ, Png CW, Weerasooriya M, Alonso S, Zhang Y. 2017 Oct. Dual-specificity Phosphatase 12 Targets p38 MaP Kinase to regulate Macrophage response to intracellular Bacterial infection. Frontiers in Immunology. 8:1259. doi: 10.3389/fimmu.2017.01259.
  • 4. Yap SSL, Nguyen-Khuong T, Rudd PM, Alonso S. 2017 Jul. Dengue Virus Glycosylation: What Do We Know?. Frontiers in Microbiology. 8:1415. doi: 10.3389/fmicb.2017.01415.
  • 5. Kalia NP, Hasenoehrl EJ, Rahman NBA, Koh VH, Ang MLT, Sajorda DR, Hards K, Grüber G, Alonso S, Cook GM et al. 2017 Jul. Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection. Proceedings of the National Academy of Sciences of the United States of America. 114(28):7426-7431. doi: 10.1073/pnas.1706139114/-/DCSupplemental.